Bacteroides are associated with GALT iNKT cell function and reduction of microbial translocation in HIV-1 infection

Mucosal Immunology

Volumn 10, Issue 1, 2017, Pages 69-78

  Paquin Proulx, D ^a   Ching, C ^b   Vujkovic Cvijin, I ^b   Fadrosh, D ^b   Loh, L ^b,d   Huang, Y ^c   Somsouk, M ^b   Lynch, S V ^b   Hunt, P W ^b   Nixon, D F ^a   Sengupta, D ^b  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; INTERLEUKIN 10; INTERLEUKIN 4; CD1D ANTIGEN; LIPID;

ADULT; ARTICLE; BACTERIAL TRANSLOCATION; BACTEROIDES; BLOOD ANALYSIS; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE DURATION; DYSBIOSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOREACTIVITY; INTESTINE LYMPHATIC TISSUE; LYMPHOCYTE FUNCTION; MALE; NATURAL KILLER T CELL; POPULATION ABUNDANCE; REGULATORY T LYMPHOCYTE; TH2 CELL; VIRUS LOAD; AGED; CELL CULTURE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; INNATE IMMUNITY; INTESTINE; INTESTINE FLORA; METABOLISM; MICROBIOLOGY; MIDDLE AGED; VIROLOGY; YOUNG ADULT;

ADULT; AGED; ANTIGENS, CD1D; BACTEROIDES; CELLS, CULTURED; FEMALE; GASTROINTESTINAL MICROBIOME; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-10; INTERLEUKIN-4; INTESTINES; LIPIDS; MALE; MIDDLE AGED; NATURAL KILLER T-CELLS; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 85011049927     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2016.34     Document Type: Article

References (42)

1. Miedema, F. et al. Immune activation and collateral damage in AIDS pathogenesis. Front. Immunol. 4, 298 (2013).
2. Hatano, H. Immune activation and HIV persistence: Considerations for novel therapeutic interventions. Curr. Opin. HIV AIDS 8, 211-216 (2013).
3. Liu, Z. et al. ElevatedCD38 antigen expression onCD8+ Tcells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 16, 83-92 (1997).
4. Utay, N.S. &Hunt, P.W. Role of immune activation in progression to AIDS. Curr. Opin. HIV AIDS 11, 131-137 (2016).
5. Jain, V. et al. Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size. J. Infect. Dis. 208, 1202-1211 (2013).
6. Godfrey, D.I. et al. Antigen recognition by CD1d-restricted NKT T cell receptors. Semin. Immunol. 22, 61-67 (2010).
7. Matsuda, J.L., Mallevaey, T., Scott-Browne, J. &Gapin, L. CD1d-restricted iNKT cells, the ''Swiss-Army knife'' of the immune system. Curr. Opin. Immunol. 20, 358-368 (2008).
8. Van Kaer, L., Parekh, V.V. &Wu, L. Invariant natural killer T cells: bridging innate and adaptive immunity. Cell Tissue Res. 343, 43-55 (2011).
9. Olszak, T. et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 336, 489-493 (2012).
10. An, D. et al. Sphingolipids from a symbiotic microbe regulate homeostasis of host intestinal natural killer T cells. Cell 156, 123-133 (2014).
11. Wieland Brown, L.C. et al. Production of alpha-galactosylceramide by a prominent member of the human gut microbiota. PLoS Biol. 11, e1001610 (2013).
12. Wingender, G. et al. Intestinal microbes affect phenotypes and functions of invariant natural killer T cells in mice. Gastroenterology 143, 418-428 (2012).
13. Vujkovic-Cvijin, I. et al. Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci. Transl. Med. 5, 193ra191 (2013).
14. Diana, J. &Lehuen, A. NKTcells: friend or foe during viral infections? Eur. J. Immunol. 39, 3283-3291 (2009).
15. Juno, J.A., Keynan, Y. &Fowke, K.R. Invariant NKT cells: regulation and function during viral infection. PLoS Pathog. 8, e1002838 (2012).
16. van der Vliet, H.J. et al. Selective decrease in circulating Valpha 24+V beta 11+ NKT cells during HIV type 1 infection. J. Immunol. 168, 1490-1495 (2002).
17. Fernandez, C.S. et al. Peripheral NKT cells in simian immunodeficiency virus-infected macaques. J. Virol. 83, 1617-1624 (2009).
18. van der Vliet, H.J. et al. Cutting edge: rapid recovery of NKT cells upon institution of highly active antiretroviral therapy for HIV-1 infection. J. Immunol. 177, 5775-5778 (2006).
19. Snyder-Cappione, J.E. et al. Lower cytokine secretion ex vivo by natural killer T cells in HIV-infected individuals is associated with higher CD161 expression. AIDS 23, 1965-1970 (2009).
20. Moll, M. et al. Severe functional impairment and elevated PD-1 expression in CD1d-restricted NKTcells retained during chronic HIV-1 infection. Eur. J. Immunol. 39, 902-911 (2009).
21. Roelofs-Haarhuis,K.,Wu, X. and Gleichmann, E. Oral tolerance to nickel requires CD4+ invariant NKT cells for the infectious spread of tolerance and the induction of specific regulatory T cells. J. Immunol. 173, 1043-1050 (2004).
22. Sandberg, J.K. et al. Selective loss of innate CD4(+) V alpha 24 natural killer Tcells in human immunodeficiency virus infection. J. Virol. 76, 7528-7534 (2002).
23. Motsinger, A. et al. CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection. J. Exp. Med. 195, 869-879 (2002).
24. Fernandez, C.S., Kelleher, A.D., Finlayson, R., Godfrey, D.I. &Kent, S.J. NKTcell depletion in humans during early HIV infection. Immunol. Cell Biol. 92, 578-590 (2014).
25. Josefowicz, S.Z., Lu, L.F. &Rudensky, A.Y. Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 30, 531-564 (2012).
26. Brenchley, J.M. et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12, 1365-1371 (2006).
27. Hunt, P.W. et al. Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection. J. Infect. Dis. 210, 1228-1238 (2014).
28. Nockher, W.A., Bergmann, L. &Scherberich, J.E. Increased soluble CD14 serum levels and altered CD14 expression of peripheral blood monocytes in HIV-infected patients. Clin. Exp. Immunol. 98, 369-374 (1994).
29. Pelsers, M.M. et al. Intestinal-type and liver-type fatty acid-binding protein in the intestine. Tissue distribution and clinical utility. Clin. Biochem. 36, 529-535 (2003).
30. Lozupone, C.A. et al. HIV-induced alteration in gut microbiota: driving factors, consequences, and effects of antiretroviral therapy. Gut Microbes. 5, 562-570 (2014).
31. Dillon, S.M. et al. An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia. Mucosal Immunol. 7, 983-994 (2014).
32. Ibarrondo, F.J. et al. Preferential depletion of gut CD4-expressing iNKTcells contributes to systemic immune activation in HIV-1 infection. Mucosal Immunol. 6, 591-600 (2013).
33. Chan, A.C. et al. Ex vivo analysis of human natural killer T cells demonstrates heterogeneity between tissues and within established CD4(+) and CD4(-) subsets. Clin. Exp. Immunol. 172, 129-137 (2013).
34. Gumperz, J.E., Miyake, S., Yamamura, T. &Brenner, M.B. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 195, 625-636 (2002).
35. Lee, P.T., Benlagha, K., Teyton, L. &Bendelac, A. Distinct functional lineages of human V(alpha)24 natural killer T cells. J. Exp. Med. 195, 637-641 (2002).
36. Rout, N. et al. Loss of effector and anti-inflammatory natural killer T lymphocyte function in pathogenic simian immunodeficiency virus infection. PLoS Pathog. 8, e1002928 (2012).
37. Madsen, K.L. et al. Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora. Inflamm. Bowel Dis. 5, 262-270 (1999).
38. Nowak, P. et al. Gut microbiota diversity predicts immune status in HIV-1 infection. AIDS 29, 2409-2418 (2015).
39. Loh, L., Ivarsson, M.A., Michaelsson, J., Sandberg, J.K. &Nixon, D.F. Invariant natural killer Tcells developing in the human fetus accumulate and mature in the small intestine. Mucosal Immunol. 7, 1233-1243 (2014).
40. Gadola, S.D., Dulphy, N., Salio, M. &Cerundolo, V. Valpha24-JalphaQindependent, CD1d-restricted recognition of alpha-galactosylceramide by human CD4(+) and CD8alphabeta(+) T lymphocytes. J. Immunol. 168, 5514-5520 (2002).
41. Caporaso, J.G. et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7, 335-336 (2010).
42. Huang, Y. et al. A simple LC-MS/MS method for determination of kynurenine and tryptophan concentrations in human plasma from HIV-infected patients. Bioanalysis 5, 1397-1407 (2013).